Data for R&D

 

 

How to maximize data’s potential in drug and device research & development.

 

Data for R&D, Thursday 10 October 2019

08:00

Registration & Breakfast

Plenary Keynotes

Nevine Zariffa
08:35

Chairperson’s opening remarks

Ramesh Kolluru
08:40

Data innovation in the American government: how the HHS effectively leverages data, technology and innovation to improve lives

Gianluca Pettiti
09:00

Automating data: how AI and automation will impact the use of data applied to lab interconnectivity and sample analysis

Arpa Garay
09:20

Keynote Panel

Data strategies for R&D, addressing the importance of privacy, leveraging new technology and analytics for product commercialization, and integrating data into pharma companies.
10:20

Networking Coffee Break

Oncology

James Broach
Data for R&D
11:00

Targeting groups of cancer genes in a pathway: how to identify driver alterations within pathways and choose a targetable alteration to optimize cancer therapy

William Rickets
Andrey Loboda
Data for R&D
11:20

Cancer data mining: how to leverage the recent influx of complex molecular data in immune-oncology to understand tumor- immune interaction, identify new targets, and develop novel biomarkers

Panna Sharma
Data for R&D
11:40

Creating value through large genomic data sets: how human guided machine learning is used to analyze large patient data sets and develop novel oncology therapies

12:20

Networking Lunch

ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30 minutes – attendees can select two roundtables to attend)

Monika Schneider
13:40

Roundtable: Incentivizing orphan drug innovation: how to motivate companies to develop orphan drugs through changes to reimbursement and tax incentives

Monika Schneider, Research Associate, Margolis Center For Health Policy, Duke University
Stephan Schuster
13:40

Roundtable: Microbiomes as indicators of health: how the surrounding environment can impact human health, and an examination of the data supporting this as evidence

Fergal Mccaffery
13:40

Roundtable: Mitigating the risk of mobile healthcare

How to secure data with the influx of healthcare apps and the move to patient interaction via mobile devices by conducting more frequent HIPAA security checks and penetration-testing / vulnerability-assessments of IT systems.
Yizhen Dong
13:40

Roundtable: Multidisciplinary approaches: how to apply digital data to drug discovery, use new technology for data mining, and utilize machine learning

Jenny Royle
13:40

Roundtable: The impact of safety data collection: how to treat disease and improve the quality of life for patients while properly characterizing the effects of the drug

13:40

Roundtable: Using data to develop innovative telemedicine programs: sharing ideas for the creation and implementation of telehealth programs

Jud Schneider
13:40

Roundtable:Terabytes of data is not enough: building a better biobank via data product design, analytic services, data delivery, cloud-based analytic toolkits and other means

Pricing & Reimbursement

Xin Chen
Data for R&D
14:50

Value based assessment: how Real-World Evidence (RWE) can improve estimates of actual drug use and costs, and increase transparency in health outcomes

More information soon.
Daniel Jamieson
Data for R&D
15:10

Transforming insight access: identifying companies developing similar assets, ranking experts in the field, and visualizing trends in future impact areas to support value assessment

Networking Coffee Break

Plenary Keynotes

Data Democratization

Kamal Sharma
17:50

Closing remarks followed by networking drinks reception

More information soon.
last published: 11/Oct/19 15:25

Data for R&D, Friday 11 October 2019

08:00

Registration & Breakfast

Plenary Keynotes

10:20

Networking coffee break

Rare Diseases

Jud Schneider
Data for R&D
11:00

EMR: how using Electronic Medical Record data and genetic data accelerates drug discovery, development and RWE applications

Xin Du
Data for R&D
11:20

FDA updates for rare disease data: how to approach rare disease data and make company-wide updates to improve data submission

Xin Du, Senior Vice President And Head Of Global Regulatory Affairs, Adlai Nortye Biopharma
Data for R&D
11:40

Data sharing for rare diseases: assessing the importance of data sharing for rare disease product development

Monica Weldon
Data for R&D
11:40

Real world data for rare diseases: how to make drug development more feasible for rare diseases and improve regulatory decision making

More information soon.
12:20

Networking Lunch

June Lee
13:40

Roundtable: AI for therapeutics: how to apply automation and machine learning to treatments and encourage the use of AI beyond drug discovery

Jud Schneider
13:40

ROUNDTABLE: AI integration: how incorporating AI into all phases of drug development from target discovery, to the recovery of failed projects is transforming pharma

Amelia Anderson
13:40

Roundtable: Computational molecular dynamics: small molecule data approaches for modifying drugs and identifying targets

Stephanie Monroe
13:40

Roundtable: Data to Eliminate Health Disparities

Addressing the need for diversity in clinical trials and treatment by strategizing locations of research centers and clinics, creating accessible physician support, and using data to target individuals for outreach
Nadeem Sarwar
13:40

Roundtable: Genomics in drug discovery: how to expedite the drug development through genomics and structural/cultural changes

Eve Bukowski
13:40

Roundtable: Strategic data presentations for government support

How to engage government officials by shifting from the use of quantitative data (hard numbers) to qualitative data (telling the patient story) in your presentation.
Eve Bukowski, Vice President, Patient Advocacy, Education and Outreach, California Life Sciences Association - CLSA
Hollie Schmidt

ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30 minutes – attendees can select two roundtables to attend)

Non-Clinical Data

15:30

End of Conference

last published: 11/Oct/19 15:25

 

Contact us

To sponsor or exhibit contact:
André Singer
t/ 646.619.1797 

andre.singer@terrapinn.com


To speak:
Anna Bagley
t/ 646 619-1803 

anna.bagley@terrapinn.com